<DOC>
	<DOCNO>NCT01913704</DOCNO>
	<brief_summary>The purpose study determine effectiveness NatroxTM Topical Oxygen device versus placebo patient non-healing leg ulceration conjunction standard best practice .</brief_summary>
	<brief_title>Pilot Study Comparing NatroxTM Topical Oxygen Therapy A Placebo Management Non-Healing Leg Ulcers</brief_title>
	<detailed_description>Patients screen two week enrollment ass whether ulcer `` non-healing '' , define reduction wound surface &lt; 25 % two week standard best practice wound care . On enrolment randomisation active placebo treatment patient treat six week 100 % epithelialisation , whichever sooner , treatment revert standard best practice , define moist wound heal plus compression appropriate . The reference ulcer follow two week six week end active treatment period .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Skin Ulcer</mesh_term>
	<criteria>Patients superficial venous mixed aetiology leg ulcer flat plane surface area 450cm2 Patients diabetes may include provide good metabolic control Patients understand trial , agree adhere treatment able give consent Patients follow investigate team whole period participation study Patients present wound clinically infected require antimicrobial therapy . Patients treat wound infection antimicrobial therapy ( systematically topically ) may include provide wound long assess infect two week washout period last treatment patient reassess inclusion exclusion criterion Patients know sensitivity component evaluation device Patients know suspected malignancy wound surround tissue Patients whose wound show percentage decrease surface area &gt; 25 % two week screen period Patients physical mental capacity , significant ability change NatroxTM battery pack daily basis Patients present 10 % wound surface area cover hard eschar Patients actively treat immunosuppressive corticosteroidal medication Patients participate another clinical trial Patients know history poor compliance medical treatment Patients trial previously withdraw Patients unable understand aim trial give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>venous leg ulcer</keyword>
	<keyword>mixed aetiology leg ulcer</keyword>
</DOC>